These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29651186)

  • 1. In-Vitro Activity of Doxycycline and β-Lactam Combinations Against Different Strains of
    Mohamad NI; Harun A; Hasan H; Deris ZZ
    Indian J Microbiol; 2018 Jun; 58(2):244-247. PubMed ID: 29651186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro activity of β-lactams/trimethoprim-sulfamethoxazole combinations against different strains of Burkholderia pseudomallei.
    Mohamad NI; Harun A; Hasan H; Deris ZZ
    Trop Biomed; 2022 Mar; 39(1):11-16. PubMed ID: 35225295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical microscopy reveals the dynamic nature of B. pseudomallei morphology during β-lactam antimicrobial susceptibility testing.
    McLaughlin HP; Bugrysheva J; Sue D
    BMC Microbiol; 2020 Jul; 20(1):209. PubMed ID: 32677888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis.
    Jenney AW; Lum G; Fisher DA; Currie BJ
    Int J Antimicrob Agents; 2001 Feb; 17(2):109-13. PubMed ID: 11165114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Farnesol increases the susceptibility of Burkholderia pseudomallei biofilm to antimicrobials used to treat melioidosis.
    Castelo-Branco DS; Riello GB; Vasconcelos DC; Guedes GM; Serpa R; Bandeira TJ; Monteiro AJ; Cordeiro RA; Rocha MF; Sidrim JJ; Brilhante RS
    J Appl Microbiol; 2016 Mar; 120(3):600-6. PubMed ID: 26669506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for treating melioidosis.
    Samuel M; Ti TY
    Cochrane Database Syst Rev; 2002; (4):CD001263. PubMed ID: 12519552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance in Burkholderia pseudomallei.
    Vorachit M; Chongtrakool P; Arkomsean S; Boonsong S
    Acta Trop; 2000 Feb; 74(2-3):139-44. PubMed ID: 10674642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis.
    Bonacorsi S; Fitoussi F; Lhopital S; Bingen E
    Antimicrob Agents Chemother; 1999 Feb; 43(2):213-7. PubMed ID: 9925508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burkholderia pseudomallei: in vitro susceptibility to some new and old antimicrobials.
    Karunakaran R; Puthucheary SD
    Scand J Infect Dis; 2007; 39(10):858-61. PubMed ID: 17852912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders.
    Russell P; Eley SM; Ellis J; Green M; Bell DL; Kenny DJ; Titball RW
    J Antimicrob Chemother; 2000 Jun; 45(6):813-8. PubMed ID: 10837435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of Burkholderia pseudomallei isolates in Northern Vietnam.
    Nhung PH; Van VH; Anh NQ; Phuong DM
    J Glob Antimicrob Resist; 2019 Sep; 18():34-36. PubMed ID: 30685463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological cut-off value of clinical isolates of Burkholderia pseudomallei from Northern Queensland to meropenem, ceftazidime, trimethoprim/sulfamethoxazole and doxycycline by the microbroth dilution method.
    Maloney S; Engler C; Norton R
    J Glob Antimicrob Resist; 2017 Sep; 10():291-294. PubMed ID: 28729203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of Methyltransferase Function and Increased Efflux Activity Leads to Doxycycline Resistance in Burkholderia pseudomallei.
    Webb JR; Price EP; Currie BJ; Sarovich DS
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro activity of carbapenem antibiotics against beta-lactam susceptible and resistant strains of Burkholderia pseudomallei.
    Smith MD; Wuthiekanun V; Walsh AL; White NJ
    J Antimicrob Chemother; 1996 Mar; 37(3):611-5. PubMed ID: 9182118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection.
    Sarovich DS; Price EP; Limmathurotsakul D; Cook JM; Von Schulze AT; Wolken SR; Keim P; Peacock SJ; Pearson T
    Infect Drug Resist; 2012; 5():129-32. PubMed ID: 22977307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silver Nanoparticles Enhance Antimicrobial Efficacy of Antibiotics and Restore That Efficacy against the Melioidosis Pathogen.
    Malawong S; Thammawithan S; Sirithongsuk P; Daduang S; Klaynongsruang S; Wong PT; Patramanon R
    Antibiotics (Basel); 2021 Jul; 10(7):. PubMed ID: 34356761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Do different interpretative methods used for evaluation of checkerboard synergy test affect the results?].
    Ozseven AG; Sesli Çetin E; Ozseven L
    Mikrobiyol Bul; 2012 Jul; 46(3):410-20. PubMed ID: 22951653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating New Compounds to Treat
    Ross BN; Myers JN; Muruato LA; Tapia D; Torres AG
    Front Cell Infect Microbiol; 2018; 8():210. PubMed ID: 30013953
    [No Abstract]   [Full Text] [Related]  

  • 19. Nitric oxide from IFNγ-primed macrophages modulates the antimicrobial activity of β-lactams against the intracellular pathogens Burkholderia pseudomallei and Nontyphoidal Salmonella.
    Jones-Carson J; Zweifel AE; Tapscott T; Austin C; Brown JM; Jones KL; Voskuil MI; Vázquez-Torres A
    PLoS Negl Trop Dis; 2014 Aug; 8(8):e3079. PubMed ID: 25121731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of various antibiotic combinations using the E-Test method in multiresistant Pseudomonas aeruginosa strains.
    Kocazeybek B; Arabaci U; Erentürk S; Akdur H
    Chemotherapy; 2002 Mar; 48(1):31-5. PubMed ID: 11901254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.